Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy (Q33821554)

29 July 2017

1 reference

11 September 2020

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy (English)

1 reference

renal replacement therapy

29 July 2017

1 reference

11 September 2020

1 reference

23 July 2019

1 reference

7 November 2019

1 reference

11 September 2020

1 reference

25042938

author

Mireia Llaurado-Serra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

Caridad Pontes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Marta Ulldemolins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

Sergi Vaquer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

Gonzalo Calvo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

Dolors Soy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

Ignacio Martín-Loeches

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

1 reference

23 June 2014

9 references

29 July 2017

23 March 2019

22 June 2019

25 June 2019

23 July 2019

4 August 2019

17 September 2019

7 November 2019

11 September 2020

9 references

23 March 2019

22 June 2019

25 June 2019

23 July 2019

4 August 2019

17 September 2019

7 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

11 September 2020

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 June 2020

copyright license

8 references

23 March 2019

22 June 2019

25 June 2019

23 July 2019

4 August 2019

17 September 2019

7 November 2019

on focus list of Wikimedia project

11 September 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Therapeutic drug monitoring of antimicrobials

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

The relevance of drug volume of distribution in antibiotic dosing

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Clinical review: Optimal dose of continuous renal replacement therapy in acute kidney injury

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Intensity of continuous renal-replacement therapy in critically ill patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Principles of antibacterial dosing in continuous renal replacement therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Pharmacokinetic issues for antibiotics in the critically ill patient

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Intensity of renal support in critically ill patients with acute kidney injury

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Standard versus high-dose CVVHDF for ICU-related acute renal failure.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Antibacterial dosage in intensive-care-unit patients based on pharmacokinetic/pharmacodynamic principles

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Dosage of antipseudomonal antibiotics in patients with acute kidney injury subjected to continuous renal replacement therapies

4 July 2018

1 reference

Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose

21 January 2018

1 reference

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

21 January 2018

1 reference

The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients

21 January 2018

1 reference

Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.

21 January 2018

1 reference

Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration

21 January 2018

1 reference

Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.

21 January 2018

1 reference

Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy

21 January 2018

1 reference

Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration

21 January 2018

1 reference

Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients

21 January 2018

1 reference

Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration

21 January 2018

1 reference

Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis.

21 January 2018

1 reference

Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure

21 January 2018

1 reference

Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075152

Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia

29 October 2018

1 reference

Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH)

21 January 2018

1 reference

Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration

21 January 2018

1 reference

12 December 2020

Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: evaluation of the sieving coefficient

1 reference

12 December 2020

Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure

1 reference

12 December 2020

1 reference

12 December 2020

Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial

1 reference

12 December 2020

Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure

1 reference

12 December 2020

Antibiotic dose adjustment in the treatment of MRSA infections in patients with acute renal failure undergoing continuous renal replacement therapies

1 reference

12 December 2020

High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial

1 reference

12 December 2020

A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy

1 reference

12 December 2020

Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration

1 reference

12 December 2020

Aminoglycoside volume of distribution and illness severity in critically ill septic patients

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration.

1 reference

12 December 2020

Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration

1 reference

12 December 2020

Meropenem pharmacokinetics in a patient with multiorgan failure from Meningococcemia undergoing continuous venovenous hemodiafiltration

1 reference

12 December 2020

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

12 December 2020

Identifiers

DOI

10.1186/CC13938

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json

13 June 2020

25042938

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25042938 AND SRC:MED&resulttype=core&format=json